Table 5.
Pneumococcal vaccination by gender, place, and vaccine type.
| Variable | Pneumococcal Vaccination N (%) | Completed Schedule N (%) | ||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | p | Vaccinated Completely | Not Fully Vaccinated | Not Vaccinated | p | ||
| Gender | Male | 608 (73.1) | 224 (26.9) | 0.886 | 608 (73.1) | 99 (11.9) | 125 (15.0) | 0.989 |
| Female | 560 (73.4) | 203 (26.6) | 560 (73.4) | 90 (11.8) | 113 (14.8) | |||
| Place | Urban area | 933 (70.8) | 385 (29.2) | <0.001 | 933 (70.8) | 171 (13.0) | 214 (16.2) | <0.001 |
| Rural area | 235 (84.8) | 42 (15.2) | 235 (84.8) | 18 (6.5) | 24 (8.7) | |||
| Vaccine | PCV10 1 | — | — | — | 700 (87.4) | 101 (12.6) | — | 0.093 |
| PCV13 2 | — | — | 468 (84.2) | 88 (15.8) | — | |||
1 PCV10—10-valent conjugate pneumococcal vaccine; 2 PCV13—13-valent conjugate pneumococcal vaccine.